Literature DB >> 30693420

The Role of Log Odds of Positive Lymph Nodes in Predicting the Survival after Resection for Ampullary Adenocarcinoma.

Cihan Agalar1, Anıl Aysal2, Tarkan Unek3, Tufan Egeli3, Mucahit Ozbilgin3, Nesrin Akturk4, Huseyin Salih Semiz5, Tugba Unek5, Mesut Akarsu6, Müjde Soyturk6, Hulya Ellidokuz7, Ozgul Sagol2, Ibrahim Astarcioglu3.   

Abstract

Lymph node metastasis is a important factor on survival in ampullary adenocarcinoma. Log odds of positive lymph nodes (LODDS) is a novel prognostic indicator on lymph node status. We aimed to evaluate the prognostic impact of LODDS for the patients with ampullary adenocarcinoma who underwent R0 pancreaticoduodenectomy. The study includes 42 patients.. LODDS was calculated as "log (number of metastatic lymph nodes+0.5)/(number of total harvested nodes - metastatic lymph nodes+0.5)". LODDS subgroups were created based on their LODDS value: LODDS1(LODDS≤ - 1.5), LODDS2(-1.5 < LODDS≤ - 1.0), LODDS3(-1.0 < LODDS≤ - 0.5), LODDS4(LODDS> - 0.5). The mean survival time was 72.7 ± 7.82 months. Survival rates for 1, 3 and 5 years were 93%, 65% and 45%, respectively. The mean LODDS value was -1.0466 ± 0.51. LODDS subgroups show strong correlation with Overall Survival(OS). The mean survival were 114.8, 81.8, 56.6 and 25.6 months in LODDS subgroups 1, 2, 3 and 4, respectively (Log-rank; p = 0.002), in addition LOODS values shows correlation with perineural invasion and micro vascular invasion (p = 0.015 and p = 0.001 respectively). Findings in our patient group support the hypothesis that LODDS subgroups correlate with OS, and that value of LODDS has considerable role in prediction of OS as well.

Entities:  

Keywords:  Ampullary adenocarcinoma; LODDS; Log odds of positive lymph nodes; Microvascular invasion; Perineural invasion

Year:  2019        PMID: 30693420     DOI: 10.1007/s12253-019-00584-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  33 in total

1.  Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability.

Authors:  Fausto Sessa; Daniela Furlan; Clementina Zampatti; Ileana Carnevali; Francesca Franzi; Carlo Capella
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.064

2.  Prognostic assessment of different lymph node staging methods for pancreatic cancer with R0 resection: pN staging, lymph node ratio, log odds of positive lymph nodes.

Authors:  Marco La Torre; Giuseppe Nigri; Niccolò Petrucciani; Marco Cavallini; Paolo Aurello; Giulia Cosenza; Genoveffa Balducci; Vincenzo Ziparo; Giovanni Ramacciato
Journal:  Pancreatology       Date:  2014-06-14       Impact factor: 3.996

3.  Pattern analysis of lymph node metastasis and the prognostic importance of number of metastatic nodes in ampullary adenocarcinoma.

Authors:  Jae Hoon Lee; Kyeong Geun Lee; Tae Kyung Ha; Young Jin Jun; Seung Sam Paik; Hwon Kyum Park; Kwang Soo Lee
Journal:  Am Surg       Date:  2011-03       Impact factor: 0.688

4.  Surgical outcomes and prognostic factors for ampulla of Vater cancer.

Authors:  S B Choi; W B Kim; T J Song; S O Suh; Y C Kim; S Y Choi
Journal:  Scand J Surg       Date:  2011       Impact factor: 2.360

Review 5.  Ratio and log odds of positive lymph nodes in breast cancer patients with mastectomy.

Authors:  Li-Ju Chen; Kuo-Piao Chung; Yao-Jen Chang; Yun-Jau Chang
Journal:  Surg Oncol       Date:  2015-05-19       Impact factor: 3.279

6.  The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma.

Authors:  Timothy N Showalter; Tingting Zhan; P Rani Anne; Inna Chervoneva; Edith P Mitchell; Charles J Yeo; Ernest L Rosato; Eugene P Kennedy; Adam C Berger
Journal:  J Gastrointest Surg       Date:  2011-04-27       Impact factor: 3.452

7.  Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program.

Authors:  Jorge Albores-Saavedra; Arnold M Schwartz; Kristen Batich; Donald E Henson
Journal:  J Surg Oncol       Date:  2009-12-01       Impact factor: 3.454

8.  Survival analysis after pancreatic resection for ampullary and pancreatic head carcinoma: an analysis of clinicopathological factors.

Authors:  C A M Sommerville; P Limongelli; M Pai; R Ahmad; G Stamp; N A Habib; R C N Williamson; L R Jiao
Journal:  J Surg Oncol       Date:  2009-12-15       Impact factor: 3.454

9.  Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.

Authors:  Luciana Bertocco de Paiva Haddad; Rosely Antunes Patzina; Sônia Penteado; André Luiz Montagnini; José Eduardo Monteiro da Cunha; Marcel Cerqueira César Machado; José Jukemura
Journal:  J Gastrointest Surg       Date:  2010-01-27       Impact factor: 3.452

10.  Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS).

Authors:  Johanna A M G Tol; Dirk J Gouma; Claudio Bassi; Christos Dervenis; Marco Montorsi; Mustapha Adham; Ake Andrén-Sandberg; Horacio J Asbun; Maximilian Bockhorn; Markus W Büchler; Kevin C Conlon; Laureano Fernández-Cruz; Abe Fingerhut; Helmut Friess; Werner Hartwig; Jakob R Izbicki; Keith D Lillemoe; Miroslav N Milicevic; John P Neoptolemos; Shailesh V Shrikhande; Charles M Vollmer; Charles J Yeo; Richard M Charnley
Journal:  Surgery       Date:  2014-07-22       Impact factor: 3.982

View more
  4 in total

1.  Development and Validation of a New Lymph Node Ratio-Based Staging System for Ampullary Carcinoma After Curative Pancreaticoduodenectomy.

Authors:  Xiaojie Zhang; Chongyuan Sun; Zefeng Li; Tongbo Wang; Lulu Zhao; Penghui Niu; Chunguang Guo; Yingtai Chen; Xu Che; Dongbing Zhao
Journal:  Front Oncol       Date:  2022-01-20       Impact factor: 6.244

2.  N, LNR or LODDS: Which Is the Most Appropriate Lymph Node Classification Scheme for Patients with Radically Resected Pancreatic Cancer?

Authors:  Dimitrios Prassas; Sami Alexander Safi; Maria Chara Stylianidi; Leila Anne Telan; Sarah Krieg; Christoph Roderburg; Irene Esposito; Tom Luedde; Wolfram Trudo Knoefel; Andreas Krieg
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

3.  Comparison of Different Lymph Node Staging Schemes for Predicting Survival Outcomes in Node-Positive Endometrioid Endometrial Cancer Patients.

Authors:  Xi-Lin Yang; Nan Huang; Ming-Ming Wang; Hua Lai; Da-Jun Wu
Journal:  Front Med (Lausanne)       Date:  2021-07-09

4.  Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study.

Authors:  Yue Yu; Peng Zhang; Renqi Yao; Junnan Wang; Pei Wang; Xiaofei Xue; Jian Xiao; Zhinong Wang
Journal:  Transl Lung Cancer Res       Date:  2020-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.